5, 28, 12.5 and 15 dB nHL. It required 21.2 (+/-5) min on average to obtain threshold in each ear in neonates, with a range of 12-29 min. When ASSR thresholds recorded in full-term neonates GSK1210151A price and adults were directly compared, the differences between these groups were not significant for 1000 Hz (p = 0.500), 2000 Hz (p = 0.610) and 4000 Hz (p = 0.362). However, at 500 Hz, ASSR thresholds in neonates tend to be greater than in adults (p = 0.001).

Conclusion: In this study ASSR thresholds estimated from 90% of the neonates were 34.5, 28, 12.5 and 15 dB nHL. It required 21.2 (+/-5) min on average to obtain threshold in each ear and ASSR thresholds

to narrow band CE-chirp (R) in neonates are not significant for adults ASSR thresholds, except at 500 Hz, when the ASSR thresholds in neonates tend to be greater than in adults. (C) 2013 Elsevier Ireland Ltd. All rights reserved.”
“The pathogenesis BEZ235 in vivo of acute coronary syndrome is rupture of vulnerable plaque. Extracellular matrix metalloproteinase inducer (EMMPRIN) is reported to have a important role in the destabilization of atheroma. Objectives: this investigation examined the effect of angiotensin II (Ang II) on EMMPRIN expression in atherosclerotic plaques in ApoE knockout mice. Methods: ApoE knockout

mice were fed a high fat diet to establish an atherosclerosis model then intervention was made with Ang II and valsartan. EMMPRIN gene and its protein expression were measured by real-time PCR immunohistochemistry, 5-Fluoracil concentration and Western blot. Results: EMMPRIN gene and protein expression intervened with Ang II were significantly increased; valsartan could inhibit the effect of Ang II. Conclusion: Ang II up-regulated EMMPRIN expression in atherosclerotic plaque via AT1R, and valsartan could inhibit the effect of Ang II.”
“Objective: GJB2 mutation is recognized as the prevalent causes of non-syndromic hearing

loss (NSHL) worldwide. However, the mutation profiles of GJB2 are rarely reported in deafness probands of the assortative mating family. Therefore, this study aimed to characterize the frequencies. of GJB2 mutations in probands with hearing loss in the assortative mating family in Hubei province, Central China.

Methods: Genomic DNA was extracted from blood samples of 29 probands with hearing loss. The target fragments were amplified by polymerase chain reaction (PCR) and subjected to sequencing to identify sequence variations.

Results: None of 29 probands harbored homozygous mutation in GJB2, while GJB2 heterozygous mutations c.134G>A, c.139G>T, and a deletion c.235delC were identified in three probands, respectively.

Conclusion: GJB2 mutations are rare in Chinese probands of assortative mating families. Screening for responsible genes other than GJB2 is necessary for NSHL in these probands. (C) 2013 Elsevier Ireland Ltd. All rights reserved.